Scholarlink

<p>Long non-coding RNAs (lncRNAs) have emerged as crucial regulators of various biological processes, including gene expression, cell differentiation, and response to external stimuli. Among them, <i>PSMG3-AS1</i> has gained attention due to its involvement in the regulation of tumorigenesis across multiple cancers. This review provides an overview of the biogenesis, distribution, and functional roles of lncRNAs, with a particular focus on <i>PSMG3-AS1</i> and its impact on cancer development. <i>PSMG3-AS1</i> has been shown to play an oncogenic role in diverse malignancies such as breast cancer, cervical squamous cell carcinoma, endometrial cancer, gastric cancer, Glioma, hepatocellular carcinoma, lung cancer, oral squamous cell carcinoma, and prostate carcinoma, where its overexpression correlates with poor prognosis and enhanced tumor aggressiveness. Mechanistically, <i>PSMG3-AS1</i> promotes cancer progression by interacting with multiple regulatory networks, including miRNA-mediated pathways and epigenetic modifications, which influence key cellular processes such as proliferation, migration, and invasion. By functioning as a molecular sponge for specific miRNAs, <i>PSMG3-AS1</i> modulates the tumor-suppressive effects of these miRNAs, contributing to an oncogenic environment. Additionally, the ability of <i>PSMG3-AS1</i> to regulate gene expression through DNA methylation further underscores its role in cancer progression. The accumulating evidence suggests that <i>PSMG3-AS1</i> may serve as both a prognostic biomarker and a potential therapeutic target. However, further research is necessary to fully understand the molecular mechanisms by which <i>PSMG3-AS1</i> influences cancer biology and to explore its clinical implications in cancer diagnosis and treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unveiling the oncogenic functions of lncRNA PSMG3-AS1: a review of its biological roles in cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Hui Zhang,
  • Xin Wang

摘要

Long non-coding RNAs (lncRNAs) have emerged as crucial regulators of various biological processes, including gene expression, cell differentiation, and response to external stimuli. Among them, PSMG3-AS1 has gained attention due to its involvement in the regulation of tumorigenesis across multiple cancers. This review provides an overview of the biogenesis, distribution, and functional roles of lncRNAs, with a particular focus on PSMG3-AS1 and its impact on cancer development. PSMG3-AS1 has been shown to play an oncogenic role in diverse malignancies such as breast cancer, cervical squamous cell carcinoma, endometrial cancer, gastric cancer, Glioma, hepatocellular carcinoma, lung cancer, oral squamous cell carcinoma, and prostate carcinoma, where its overexpression correlates with poor prognosis and enhanced tumor aggressiveness. Mechanistically, PSMG3-AS1 promotes cancer progression by interacting with multiple regulatory networks, including miRNA-mediated pathways and epigenetic modifications, which influence key cellular processes such as proliferation, migration, and invasion. By functioning as a molecular sponge for specific miRNAs, PSMG3-AS1 modulates the tumor-suppressive effects of these miRNAs, contributing to an oncogenic environment. Additionally, the ability of PSMG3-AS1 to regulate gene expression through DNA methylation further underscores its role in cancer progression. The accumulating evidence suggests that PSMG3-AS1 may serve as both a prognostic biomarker and a potential therapeutic target. However, further research is necessary to fully understand the molecular mechanisms by which PSMG3-AS1 influences cancer biology and to explore its clinical implications in cancer diagnosis and treatment.